Purpose: Using our chelate-free, heat-induced radiolabeling (HIR) method, we show that a wide range of metals, including those with radioactive isotopologues used for diagnostic imaging and radionuclide therapy, bind to the Feraheme (FH) nanoparticle (NP), a drug approved for the treatment of iron anemia. Material and methods: FH NPs were heated (120°C) with nonradioactive metals, the resulting metal-FH NPs were characterized by inductively coupled plasma mass spectrometry (ICP-MS), dynamic light scattering (DLS), and r 1 and r 2 relaxivities obtained by nuclear magnetic relaxation spectrometry (NMRS greater than 85% and RCPs were greater than 95% in all cases. Conclusion: The chelate-free HIR technique for binding metals to FH NPs has been extended to a range of metals with radioisotopes used in therapeutic and diagnostic applications. Cations with f-orbital electrons, more empty d-orbitals, larger radii, and higher positive charges achieved higher values of RCY and RCP in the HIR reaction. The ability to use a simple heating step to bind a wide range of metals to the FH NP, a widely available approved drug, may allow this NP to become a platform for obtaining radiolabeled nanoparticles in many settings.
Introduction
Radiolabeling methods yield nanomaterials used for the therapy and diagnosis of cancers [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] including for therapy of liver cancer (microspheres, arterial infusion), [11] [12] [13] [14] [15] and for sentinel lymph node delineation. [16] [17] [18] [19] [20] [21] Here we examine a wide range of metals including many with radioactive isotopes used for diagnostic imaging or radionuclide therapy, for their ability to bind to the superparamagnetic iron oxide (SPION) nanoparticle (NP) known as Feraheme (FH), a drug approved for treating iron anemia and used off label as an MR contrast agent. [22] [23] [24] [25] Using our chelate free, heat-induced radiolabeling (HIR) method, [26] [27] [28] [29] we show that this drug can be used as a broad nano-platform for radioisotope labeling. Our radiolabeling method uses the Feraheme (FH), a NP with an iron oxide core (diameter~5 nm) surrounded by a 10 nm thick polymeric coating (carboxymethyldextran, CMD), giving it an overall diameter of about 25 nm and a formula of Fe 5874 O 8752 :C 11719 H 18682 O 9933 Na 414 (See Figure 1A) . Publications on the physical properties, pharmacokinetics (PK), toxicity and efficacy of FH as an MRI contrast agent provide knowledge regarding the likely behavior of radiolabeled FH in clinical settings, a body of knowledge unavailable with many other newly synthesized radiolabeled nanomaterials.
Current SPION radiolabeling methods fall into three classes. In the first class, a chelator is attached to a SPION by conjugation chemistry, followed by radiolabeling. [30] [31] [32] Storage of the chelator-modified SPIONs can be problematic due to the poisoning of the chelator by NP derived cations. In addition, the optimal chelator for in vivo stability can be different for different radiocations, and selecting a chelator can be a highly challenging task. [33] [34] [35] The second class of methods adds the radiocation during NP synthesis, so that the radiometal is incorporated throughout the metal oxide core. [36] [37] [38] [39] This technique requires isotopes with long radiochemical half-lives compared to the time of synthesis and generates considerable volumes of low-level radioactive waste from washing the NP. The third class is the radiocation surface adsorption (RSA) methods. RSA methods allow cations to bind to the surface of a previously synthesized SPION. [40] [41] [42] With our HIR RSA method, heat is used to increase the bonding to the FH iron oxide [26] [27] [28] [29] (see Figure 1A) . showed enhanced uptake at the site of injury and in the draining lymph nodes. 29 HIR and surface click chemistry modification of FH also work cooperatively to provide a versatile nanoparticle platform for biomedical applications such as ex vivo cell labeling [27] [28] [29] and in vivo cell tracking including isolated B cells. 43 An aim of this study was to investigate the HIR reaction for a range of therapeutic metals and to extend the use of the HIR radiolabeling technique for the development of a therapeutic/ diagnostic FH platform ( 64, 67 Cu]Cu-FH). A second aim was to further optimize the HIR technique to achieve higher radiochemical yield (RCY) for relatively short-lived isotopes (eg, copper-64). As far as we are aware, this study is the first attempt to radiolabel . We anticipate the results of this work would facilitate the rapid development of chelate-free radiolabeling with diverse therapeutic/diagnostic metal isotopes with predictable and reliable specific activities.
Materials and Methods
The nonradioactive metal-FH HIR experiments were performed with 12 were used as substitutes for Ra isotope (all isotopes of radium are highly radioactive) and most of the others were directly corresponding to their therapeutic isotopic counterparts (see Table 1 and Figure 1A ). In addition, ). The chelex-treated water (CTW, pH=10) was made as reported before. 29 Relaxation times were determined on a Bruker Mini SPEC MQ20, and particle sizes determined on a Malvern Instruments, ZetaSizer Nano Series, Nano-ZS. Figure 1B ) and the reactions and ICP-MS analysis ( Figure 1C ) were performed as per following:
Procedure for PD-10 SEC Fraction Collection
The PD-10 column was calibrated by FH NPs as the larger molecular marker and vitamin B 12 as the small molecular marker. The dead volume for separating the FH NPs from small molecular contaminants (eg, metal chelated DFO) was 2.5 mL. The FH NP fraction was the next 1.8 mL from 2.5 to 4.3 mL and the vitamin B 12 fraction was the next 6 mL from 4.3 to 10.0 mL. All the metal sample solutions (Group 2-4, Table 1 and Figure 1B) (20 M) to adjust pH to 7-8, then 8 µL of 0.5 M EDTA and 8 µL of 0.5 M DTPA chelators were added. After incubation at room temperature for 15 min, the mixtures were loaded onto PD-10 columns, respectively, eluted by 0.1 M HEPES buffer, and fraction collected as above.
Group 3: for FH incorporation of cations at room temperature (RT) (ICP-MS cation concentrations: see Column 3 of Table 1 ): to the 200 µL metal solutions (Stock solution B) (pre-adjusted to pH 7-8 as Group 2) in a 5 mL glass v-vial fitted with magnetic stir bar, FH (1 mg Fe, 33.3 µL) and 0.1 M HEPES (66.7 µL) were added. The final pH was adjusted to 8-9 by adding 2 M NaOH solutions. The reaction mixtures were stirred and incubated under RT for 2 hrs. After 8 µL of 0.5 M EDTA and 8 µL of 0.5 M DTPA were added and incubated at RT for 15 mins, the mixtures were loaded onto PD-10 columns, respectively, eluted by 0.1 M HEPES buffer, and fraction collected as above.
Group 4: for FH incorporation of cations at 120°C (HIR condition, ICP-MS cation concentrations: see Column 4 of Table 1 ): to the 200 µL metal solutions (Stock solution B) (pre-adjusted to pH 7-8 as Group 2) in a 5 mL glass v-vial fitted with magnetic stir bar, FH (1 mg Fe, 33.3 µL) and 0.1 M HEPES (66.7 µL) were added. The final pH was adjusted to 8-9 by adding 2 M NaOH solutions. The reaction mixtures were stirred and incubated under 120°C for 2 hrs. Then, the vial was cooled down to room temperature in an ice-water bath for 15 min. Next, 8 µL of 0.5 M EDTA and 8 µL of 0.5 M DTPA were added and incubated at room temperature for 15 min. Afterward, they were loaded onto PD-10 columns, respectively, eluted by 0.1 M HEPES buffer, and fraction collected as above.
Pre-Treatments of ICP-MS Samples and ICP-MS Analyses
The measurements for the concentrations of metal cations were carried out using an Agilent 8800-QQQ Inductively Coupled Plasma Mass Spectrometer (ICP-MS) system. Calibration curves were generated from commercially available standards (Sigma-Aldrich and Aristar). Metal containing solutions (Group 1 -Group 4, Figure 1B ) were weighted (around 0.1000 g/each sample) into 15 mL Falcon tubes. To the tubes were added ICP compatible matrix containing TritonX and nitric acid per manufacturer's instructions (around 4.000 g/each sample). The samples were digested at 37°C overnight prior to analysis. The ICP-MS results were presented in Tables 1 and 2 and figuratively displayed in Figures 1C, 2A and B.
Size and Relaxivity Measurements of NonRadioactive HIR Metal-FH
A solution of nonradioactive HIR metal-FH with 0.9 mM Fe was made in 0.1 M HEPES buffer for each sample. The sizes (Table 2, Figure 2C ) were measured by a Malvern Instruments, ZetaSizer Nano Series, Nano-ZS. The solutions of nonradioactive HIR metal-FH were made in three concentrations of Fe (0.9 mM, 0.3 mM, and 0.1 mM) for each sample. The relaxivities (r 1 and r 2 , Table 2 and Figure 2D ) were determined in 0.1 M HEPES buffer. FH treated under the same HIR heating condition was the references for both size and relaxivity measurements. Metal Association Due to Heating (for Figure 1C) The increase in metal association between room temperature and heated incubation was tested for each metal. The increase in association was tested using Welch's T-test with false discovery rate (FDR) controls. Figure 2A and B)
Statistical Analyses

Metal Retention After Washing (for
The effects of heating vs room temperature on metal retention after washing were tested using a paired T-Test. The percent of labeled metal retained after filtering was compared between heating and room temperature incubation for each metal.
Size (for Figure 2C) The sizes of all metal-FHs were compared to the size of un-doped Feraheme using a two-tailed Welch's T-Test, with FDR controls. Figure 2D) For each metal-FH, the slopes of the resultant relaxivity curves were compared to those of the unmodified FH NPs using ANCOVA analysis with FDR controls.
Relaxivities (for
Synthesis of Radioactive Metal-FHs Using HIR Conditions
The HIR procedure was described in previous studies. Figure S3e) . Finally, SEC analysis was performed for the purified product to calculate the RCP (Table 3) (procedure see below). Figure S3a-d) . The final purified product was then collected at 200 µL with approximately complete recovery (Supplementary Figure S3e) . Finally, SEC analysis was performed for the purified product to calculate the RCP ( (Table 3) .
For Higher Reaction Rate HIR (HRR-HIR)
Higher reaction rate was achieved by increasing the initial activity to A 0 = 22 MBq of [ 64 Cu]CuCl 2 , reacting at an elevated temperature at 140°C, and shortening the reaction time to 1 hr under magnetic stirring ( Table 3 ). The reaction rate _ R t ð Þ for HRR-HIR and HIR was estimated using the cumulative activity equation 44 (1):
whereÃ, A 0 , T and t 1=2 are the cumulative activity, the initial activity, the reaction time and the isotope half-life. The reaction rate calculations are exemplified in Supplement Materials.
For Higher Reaction Rate HIR Under Heating Vortex (HRR-HV-HIR)
The third set of [
64
Cu]Cu-FH reaction mixture was prepared similar to HRR-HIR technique, except that the heating vortex (HV) technique ( Figure S1 ) was used instead of magnetic stirrer for mixing the reaction mixture during the reaction (Table 3) .
Measurements for RCY and RCP
For both RCY and RCP analyses were performed using SEC and TLC methods. The SEC for RCY and RCP analyses recruited reported procedures. 29 Figure 3A , B and E, F) and [ 
Results
Nonradioactive Metal-FHs SEC Exclusion of Free Nonradioactive Metals by PD-10 Columns
It was critical to validate whether a simple SEC procedure by a PD-10 column could completely eliminate the free metal cations. The ICP-MS analyses indicated that all the samples in Group 2 had less than 1% metal contamination at larger molecular fractions (Column 2 of Table 1 ). This proved that a PD-10 SEC procedure could be sufficient to remove all the free metals at this scale. 
Incorporation of Nonradioactive Metal Cations
Incorporation of nonradioactive metal cations was carried out by incubating the FH and cation mixtures under both RT and heating (120°C, HIR heating condition) for 2 hrs. The collected FH fractions were analyzed by ICP-MS and the data are listed in Table 1 (RT: see Column 3; 120°C heating: see Column 4) and plotted by bar graph in Figure 1C . At RT, less than 20% incorporation of Sr, Ba, Mo, Bi, Cu, Bi, and In was found. Pb, Y, Lu, Sm, Tb, and Eu, however, had 28-37% eluted together with FH. This incorporation is likely due to the FH NP's CMD coating which contains multivalent carboxyl groups capable of metal binding. Carrying out metal incorporations onto FH at 120°C resulted in an overall increase of incorporation for all elements ( Figure 1C ). The extent of metal incorporation varied depending on the element. For s-block elements, Sr had the lowest incorporation among all the studied metals with~15% incorporation. Ba residing in the same group as Sr, however, had a 3-fold increase to~50%. , and Eu 3+ ) metals displayed the highest binding efficiencỹ 75% -91%. These ions are more likely to interact with other electron donors such as the oxygens on the surface of iron oxide core. 46 The statistical analysis indicated that all metals except for Cu and Sr showed significantly increased association due to heating, with a mean 4-fold increase. The remaining metals, Cu (p=0.0692) and Sr (p=0.0517), did not show significant increases.
Characterization of Nonradioactive Metal-FH NPs
The stability of metals incorporated with FH was assessed by a washing method. We hypothesized that loosely bound metals would pass through the 50 kDa filter during the centrifugation, while the HIR tightly bound metals shall be retained by the FH NPs. The SEC purified metal-FH NP (600 µL) was transferred into a 50k Da molecular cutoff Amicon filter and centrifuged under 5000g rcf at 4°C until the volume reduced down to 100 µL. Then, the concentrated metal-FH NPs were washed by 0.1 M HEPES buffer (2 × 300 µL). The washed samples were analyzed by ICP-MS and the cation concentrations are given in Table 2 and shown in Figure 2A and 53E-07 ). This is a solid evidence of the tight binding of metals when doped under 120°C (HIR) conditions. In addition to the stability of doped metals, the particle sizes ( Table 2 and Figure 2C ) and relaxivities (r 1 and r 2 , Table 2 and Figure 2D ) were also measured to characterize the HIR metal-FH NPs. A small but significant size increase (7.38 nm mean increase in diameter) was found for HIR metal-FH NPs comparing with FH NPs treated under the same condition without metals. However, the sizes are still in the reported range of FH NPs (20-33 nm in diameter). [47] [48] [49] The relaxivity measurements (Table 2 and Figure 2D ) indicate that r 1 and r 2 are in the same range as FH after the metal HIR doping, with r 1 remaining practically unchanged and r 2 with a mean increase of 6.43 s 
Radioactive Metal-FHs
Both SEC and TLC were employed for the evaluation of the HIR radiolabeling yield (RCY) and product purity (RCP). Table 3 . Both RCY and RCP results were further confirmed with radio-TLC measurements ( Figure S4 and Figure 3E (Table 3 and Figure 3 ). For [ Figure 3 . The highest RCY was achieved by HV-HRR-HIR, ≈ 87.2 ± 1.2%. Results were further confirmed by the radio-TLC measurement ( Figure 3G and H) Figure 1C) . A small percentage of the [ 64 
Cu]
Cu-FH NP attachments to the stirrer bar might be another reason for the lower RCY (see Figure S5) . Overall, HRR-HIR technique increased the RCY by approximately 22%.
Discussion
Using our chelate-free, Heat Induced Radiolabeling (HIR) method, we show that a wide range metals, including those with radioactive isotopologues used for diagnostic imaging and radionuclide therapy, bind to the Feraheme (FH) nanoparticle (NP), a drug approved for the treatment of iron anemia. Cations with f-orbital electrons, more empty d-orbitals, larger radii, and higher positive charges achieved higher values of RCY and RCP in the HIR reaction. 
Rational for Selection of Nonradioactive Metals
Based on the previous success of the HIR reaction both with elemental cations and element oxide form, [26] [27] [28] [29] 43, 46, 50 (Table 1 and Figure 1C) ), larger radii (Cu vs Y and all f-block elements), and more positive charges (Pb 2+ vs Bi 3+ ) were ideal for HIR reactions by achieving high incorporation yields (Table 1 and Figure 1C ) and more stable binding (Table 2 and Figure 2B) Figure 3 ). Thus, one of the aspects of the HIR mechanism could be described as follows: the iron oxide core surface has a negative charge potential in a basic environment, which is mainly due to the dissociation of protons from hydroxyl groups of "Fe-OH" and formation of "Fe-O" at the FH core (SPION) surface. 51 Therefore, metal cations are prone to be attracted by the unshared electron pairs of Fe-O − . Since the ionic bond energy of metal ions with a negatively charged surface is directly proportional to their charge and inversely proportional to their internuclear distance according to Coulomb's law. 52 Therefore, metal atoms with larger radii and higher oxidation state would more readily result in smaller internuclear distance, stronger electrostatic interaction, tighter binding (Table 2 and Figure 2A and B), and hence, higher radiochemical yield (RCY) ( Table 1 and Figure 3 ).
Heat is Mandatory for HIR Higher Efficiency and Tighter Binding
In addition to the nature of the elements discussed above, heating is another driving force for the success of HIR. Metal doping takes place on the surface of iron oxide core, which has been directly supported by Temperature-dependent X-band ESR (Electron Spin Resonance) study of nonradioactive Cu-FH NP 26 46 Both of our previous studies 27, 29 and present work demonstrate that the electrostatic interaction at room temperature is insufficient for achieving high efficiency and tight metal binding, as is evidenced by low doping yield (Table 1 and Figure 1C ) and readiness for washing off (Table 2 and Figure 2A ). Conversely, a heating process is able to enhance cation diffusion through the porous CMD coating onto the core and increase the interaction energy for tighter binding attested by the higher retention of cations in FH after buffer wash (Table 2 and Figure 2B ). The doping yield is also increased (Table 1, Figure 1C) . The statistical analysis of the metal cation incorporation percentage (%) (HIR versus RT by a Welch's T-test with FDR control) indicates that heating results in a highly significant (p≤0.0324) for all but 2 metals, yielding a 4-fold increase.
Stability of Metal-FH NPs Synthesized Under HIR Condition
One of the key characters of FH NPs is its high heat stability. The typical temperature employed by HIR is 120°C, below the terminal sterilization (121°C) of the FH NP manufacture. 53 This study presents the stability by the minimal alterations of the metal-FH NPs' physical properties such as the particle sizes and relaxivities (r 1 and r 2 ). The sizes have a mean increase of 7.38 nm (diameter) ( Table 2 , Figure 2C ), the r 1 values remain almost unchanged from FH, while r 2 values show a small but significant mean increase of 6.43 s −1 .mM −1 ( Table 2 , Figure 2D ). These relaxometric changes are mainly due to the use of high concentration of metals for HIR process.
Most of the metals used in these studies (eg, Tb, Eu, Sm, Y, Lu, Sr, Mo and Ba) [54] [55] [56] [57] [58] [59] [60] [61] [62] are strong paramagnetic and hence at these concentrations may affect both r 1 and r 2 measurements. However, in the case of radiolabelled FH NP for clinical diagnostic imaging, the concentration of the radiometal is usually in nano or even pico-M (eg, for labeling 92. Zr in vivo. In this study, we investigated the stabilities of the incorporated metals by a buffer washing method with centrifugation (Table 2 and Figure 2A and B). As indicated in Figure 2B , the metal cations are tightly bound to the FH NPs when the HIR condition was applied. A paired T-test was performed to compare the percentage of pre-wash metal that was retrained after a buffer wash with nanoparticles produced either with RT or HIR heating. We found a highly significant (p<0.01E-6) difference in metal retention: 47% for RT and 82% for heating.
Bremsstrahlung-Based Analysis of Nongamma Emitters
A bremsstrahlung-based technique has been developed for radiochemistry analysis of beta-emitters and alpha-emitters. 
Strategies for Improving Labeling Yield (RCY) and Specific Activity (A s )
There is a distinct A s requirement for therapeutic applications as opposed to imaging. Imaging only requires trace quantity of activity. However, high A s is critical for therapeutics, where treatment planning is required to ensure sufficient radiation dose is delivered to a tumor in a target organ. For this reason:
First, We Increased the Initial Amount of Activity
For yttrium-90 HIR, the amount of initial activity was increased from 18 MBq/1 mg Fe (which was the initial activity used for FH HIR with zirconium-89 in our previous study 26 ) to 30 MBq/1mg Fe to escalate the loading capacity. In addition, the results presented in Tables 1 and  3 (for both the HIR nonradioactive metal-FH and radioactive metal-FH NPs) have shown that we can significantly scale the A s by several orders of magnitude. Even though the clinical iron (Fe) dose could be as high as 5-7 mg/kg for iron-deficiency anemia treatment, for cancer radiation therapy, a lower FH iron dose and high A s are preferred. Additionally, this is an important factor for radiolabeling short half-life isotopes (eg, copper-64). Increasing the initial activity can provide a higher metal ion (eg, copper-64) to FH nanoparticle ratio and also provides suitable timing for workflow logistics (ie, isotope delivery). The reaction rate for different initial activity and reaction time was calculated for HRR-HIR (A 0 ≈ 22 MBq with 1 hr) and HIR (A 0 ≈ 18 MBq with 2 hrs). This analytical calculation according to Equation 1 predicted that by increasing A 0 from 18 MBq to 22 MBq and decreasing the reaction time from 2 hrs to 1 hr, the initial reaction rate increases by 19% (step by step calculation: see "Supplemental Material"), which is consistent with the experimental measurements for the HRR-HIR technique that increased the RCY by approximately 22%.
Second, a Heating Vortex Technique Was Developed for Mixing the Reaction Mixture
The use of a magnetic stirrer bar can cause heterogeneous mixing (FH and radioisotope ions) within the reaction volume, which may affect the RCY and cause microscale heterogeneous activity distribution within the labeled FH NPs. As the magnetite core of FH is superparamagnetic, a magnetic stirrer bar can have an impact on the reaction mixture, causing FH NPs to be more closely packed around the bar. Therefore, the magnetic stirrer bar was replaced with a heating vortex (HV) technique that was developed by assembling an orbital shaker with a silicon oil bath heater ( Figure S1 ). This technique has been applied to the yttrium-90, 26 ). Therefore, decreasing the reaction time and using higher initial activity for short half-life isotopes can improve the RCY. As we have shown in this study ( 
Significance of Chelate-Free HIR Radiolabeling
A chelator-free FH for both therapeutic and diagnostic nano-platform may potentially enhance the performance and stability of the radio-agent in vivo. There are two major physical processes that can affect the stability of chelate-based radio-agents: bond rupture and recoil effect. 64 Both of these processes result from nuclear decay of the radiolabeled isotope. Radioisotope decay that involves the production of isomeric daughter nuclides (with excited nucleus) results in internal conversion (following γ emission from nuclear de-excitation) that consequently leads to ejecting an inner electron (from K or M shells). Similarly, radioisotopes decaying via the electron capture process can self-ionize their daughter atom by removing an electron from the inner atomic shells (eg, absorption of K shell electron by nuclear proton 66 nanoparticle platforms, the chelatefree HIR method discussed in this work is also conducive to the development of multimodal imaging probes, allowing for new areas of research. Specifically, HIR generated radioactive FH NPs offer multimodal imaging such as PET 27, 29, 43 and MRI [22] [23] [24] [25] and the simultaneous MRI would be leveraged with HIR radiometal-FH nano-platform for three-dimensional radiation dosimetry studies, an area with important clinical significance. 80 
Conclusion
As noted, FH is a drug consisting of an iron oxide core surrounded by CMD. The CMD coating is heat stable, surviving both terminal sterilization during manufacture and the temperatures of the HIR reactions, with little or no change in nanoparticle size and relaxivity. The CMD coating is cation porous, exposing the iron oxide to hydrogen ions that lead to iron oxide dissolution in phagolysosomes, and allowing access for cations that bind to the iron oxide surface in the HIR reaction. Thus, the CMD-iron oxide bond of FH survives heat stresses but is cation porous, a combination of properties that, as far as we are aware, is unique to FH. 
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